managing adverse events associated with immunotherapy in bladder cancer
Published 5 years ago • 103 plays • Length 1:03Download video MP4
Download video MP3
Similar videos
-
1:46
adverse events in bladder cancer immunotherapy
-
5:24
case 3: fgfr-targeted therapy adverse events in bladder cancer
-
6:44
immunotherapy toxicity management in bladder cancer
-
39:24
adverse event identification and management in locally advanced/metastatic urothelial carcinoma
-
1:06
immunotherapy impacts in bladder cancer
-
1:03:24
bladder cancer: understanding immune-, targeted-, and antibody-based models for patient care
-
59:13
improving the management of cardiac immune-related adverse events in patients with cancer
-
1:16:00
case by case: optimizing dual immune checkpoint inhibitor combination therapies in advanced drive...
-
1:08
future treatment approaches for patients with bladder cancer
-
2:00
dr. matthew galsky on fatal adverse events associated with mtor inhibitors
-
31:39
the evolving role of antibody-drug conjugates in the treatment of urothelial carcinoma
-
28:38
managing immunotherapy-related adverse events
-
40:12
improving patient outcomes in urothelial carcinoma with novel antibody–drug conjugates
-
0:44
role of immunotherapy in bladder cancer
-
54:12
advances in bladder cancer and immunotherapy
-
47:59
advances in bladder cancer immunotherapy, with dr. arjun balar
-
52:47
complications of immunotherapy in oncology, 12/2/20
-
1:47
current and upcoming clinical trials in bladder cancer
-
1:21:32
recognizing & managing immune-related adverse events in the ed: keep patients with cancer safe